Academic Journal

P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Individual Patient Data

التفاصيل البيبلوغرافية
العنوان: P107: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: a Large Multi-Trial Analysis Based on Individual Patient Data
المؤلفون: Julia Driessen, Fer De Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. Lacasce, Peter D. Cole, Craig H. Moskowitz, Ramón. García Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée. M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
المصدر: HemaSphere, Vol 6, Pp 49-49 (2022)
بيانات النشر: Wiley
سنة النشر: 2022
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 2572-9241
Relation: http://journals.lww.com/10.1097/01.HS9.0000890996.84518.13; https://doaj.org/toc/2572-9241; https://doaj.org/article/944d942416844f119d5067af91baa190
DOI: 10.1097/01.HS9.0000890996.84518.13
الاتاحة: https://doi.org/10.1097/01.HS9.0000890996.84518.13
https://doaj.org/article/944d942416844f119d5067af91baa190
رقم الانضمام: edsbas.6A9B1F45
قاعدة البيانات: BASE
الوصف
تدمد:25729241
DOI:10.1097/01.HS9.0000890996.84518.13